Intrinsiqq
Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc. Quality Score

VIRX

Compare
Quality0

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Revenue Growth
0/100
-43.6%

Below 2%, essentially flat

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
61.4%

Heavy dilution above 5%

Margin Trend
0/100
-10534.3pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$13M

Positive debt with no FCF to service it

2017
$32.0M
$15.0M
2018
$14.0M
$15.0M
2019
$29.0M
$12.0M
2020
$20.0M
$5.00M
TTM
$21.0M
$34.0M
CashDebt
Return on Capital
0/100
-89.6%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

SourceQuality score computed from the 10-Q filed 11 Nov 2024, covering the period ending 30 Sept 2024, as reported to the SEC. Data last refreshed 14 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with VIRX

CompareIntrinsic value
ABBVAbbVie Inc.
$286.20+0.94%49
SKVISkinvisible Inc.
$0.18+0.00%0
SILOSilo Pharma Inc.
$1.73-7.98%10
CAMPCamp4 Therapeutics Corp.
$3.79-5.25%40
RANIRani Therapeutics Holdings Inc.
$0.51-12.03%10
HYPDHyperion DeFi, Inc.
$2.08-11.11%50
SERSerina Therapeutics Inc.
$1.12-6.67%40
DAREDare Bioscience Inc.
$0.41-9.96%10

Spot a number that looks wrong? Check it in VIRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing VIRX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.